CIFoundry
Back to Infinitus

Evaluation packet

Infinitus

Infinitus Systems · Revenue Cycle & Prior Auth · Prior authorization

Prepared November 22, 2026 from the public listing on CIFoundry. It shows what the public record says and what to ask the vendor. It is not a recommendation or an endorsement.

1. What the public record shows

Regulatory status
Not on record
Published evidence
Not on record
Named health-system users
Not on record
Integrations
Not on record
Data inputs
Not on record
HIPAA BAA
Not on record
SOC 2 / HITRUST
Not on record
Deployment model
Not on record

Integrations, data inputs, BAA, SOC 2, HITRUST and deployment model are reported by the vendor and not checked by us. Confirm them in writing.

From the vendor's published materials

Found by our team on the vendor's own pages. Each links to its source. This is what the vendor states publicly, not an audit; confirm it in the contract.

Single sign-on
Yes, uses the customer's SSOsource, checked Nov 10, 2026

2. Evaluation checklist for your role

Each question shows what the public record says: on record (with its source), reported by the maker, or not on record. It is a list of things to check, not a score.

For every reviewer

Administrator & finance

Your ticks and notes stay in this browser. Nothing is sent to us.

3. Gaps to raise with the vendor

Based on what is missing or worth confirming in this tool’s public record.

  1. No regulatory status is listed. Ask whether the tool is regulated by the FDA as a medical device and, if so, for the clearance number and the exact cleared intended use.
  2. No published study is linked. Ask for peer-reviewed validation done outside the developer’s own sites, and for results on patients and equipment like yours.
  3. We found no public reports naming health systems that use it. Ask for reference sites similar to yours and contact them yourself.
  4. Where is data stored and processed (cloud region, on-premises), and which subcontractors, including any large-language-model provider, touch patient data?
  5. How does it integrate with your EHR or imaging system, and where do results appear for the clinician?
  6. Is your data used to train the vendor’s models, and can it be deleted when the contract ends?

4. Questions for this kind of tool

From our Revenue cycle and prior authorization AI guide.

Coding and documentation integrity

Use this section if the tool suggests or assigns diagnosis and procedure codes or E/M levels, or prompts clinicians to document more specifically.

Questions to ask

  • What is audit accuracy against certified coders, by specialty and code family (ICD-10-CM, CPT, E/M)?
  • For autonomous coding, what share of charts go out with no human touch, and how accurate are those charts on audit?
  • Can we see the evidence in the note behind every code?
  • Who indemnifies us if a systematic error is found?

Test it locally

  • Have independent coders audit a meaningful sample per specialty before and after go-live.
  • Compare the monthly E/M level distribution with benchmarks. A rule that consistently raises levels leaves a pattern regulators can follow.

Red flags

  • Fees as a share of "recovered revenue" with no audit accountability
  • No explanation of why a code was chosen
  • Guaranteed revenue lift
  • No coder-in-the-loop option

5. Questions for every tool

The 12 questions that apply to every tool

Fit and evidence

  • Intended use. Does the stated use match the patients, setting, user and decision you plan to use it for?
  • Evidence level. From weakest to strongest: vendor-internal test, retrospective external validation, prospective "silent" run, prospective live study, randomized trial, proven change in outcomes. Ask which level the claims rest on and look for peer-reviewed external validation.
  • Population and equipment. Ask for results by age, sex, race and ethnicity, language and payer, and, where relevant, skin type and body habitus. Ask for results on your scanner or device vendors, EHR and protocols.
  • Local validation. Before go-live, run the tool on your own recent cases and compare it to ground truth. Agree in the contract on what counts as passing.

Workflow and people

  • Workflow cost. Count clicks, alerts per clinician per shift, minutes added per case, and who acts on the output. A strong tool that nobody acts on has no value.
  • Integration. Native EHR or PACS integration or a separate window? Single sign-on? Where do results land?
  • Human oversight. Who has the final say, how are disagreements with the tool handled, and how do you guard against over-reliance? Train users on known failure modes, not just features. Explanations matter most for risk scores and decision support.

After go-live

  • Monitoring. Who checks for drift, how often, and what triggers a pause? Re-check after vendor updates, scanner or EHR changes, and shifts in your patient population. Agree in advance on the results that would retire the tool.
  • Model updates. Version control, advance notice of changes, and the right to stay on a version you validated.

Data, liability and money

  • Data rights and security. BAA, where data is stored and processed, encryption, retention, SOC 2 or HITRUST, whether your data trains the vendor's models, the list of subcontractors that touch patient data (including any large-language-model provider), and whether data can be deleted.
  • Liability and patient notice. Who is liable when AI-assisted care goes wrong is still unsettled, and responsibility currently stays with the clinicians and organizations using the tool. Ask your malpractice carrier, and cover indemnification, audit rights and incident reporting in the contract. Joint Commission and CHAI guidance says patients should be told when AI directly affects their care, with consent where relevant.
  • Money and exit. Pricing model, any real payment pathway, the return you will measure, termination for performance failure, data return, and no auto-renewal without a performance review.

6. Notes and decision

Problem we want to solve and how we will measure it

Vendor answers and follow-ups

Local test plan and what counts as passing

Decision, owner and next step

CIFoundry is an independent, vendor-neutral directory. Listing is free, and no one can pay to change a listing or this packet. Check every fact with the vendor and the primary source before relying on it.